8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001628280-23-022677
Executive or director change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading cdxc-20230615.htm…